$50.60
-0.63-1.23%
Last update: Nov 12, 9:02 AM
GSK PLC
GSKNYSE
GSK rose 6.6% from $48.07 to $51.23, behind the S&P 500's +11.2%. Its worst day was Apr 29 (−5.6%), and its low came Nov 20 at $46.11.
Nov 12, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
GSK closed at its lowest level of the year, 4.1% below where the year started.
−0.5% · S&P 500 −1.5%
EPS of $0.68 beat the $0.64 estimate on $11.5B revenue (est. $11.2B); FY revenue guidance of $44.8B–$45.6B against the $44.4B consensus.
Story events cover the past 12 months · Times ET
+7.3%, the year's best day · S&P 500 −0.5%
GSK closed at its highest level of the year, 27.3% above where the year started.
+0.5% · S&P 500 +0.5%
EPS of $1.25 beat the $1.17 estimate on $10.3B revenue (est. $10.2B); FY revenue guidance of $53.2B.
−5.6%, the year's worst day · S&P 500 0.0%
GSK shares rose 4.6%, while the S&P 500 fell 0.1%.
+4.6% · S&P 500 −0.1%
EPS of $1.35 beat the $1.27 estimate on $11.3B revenue (est. $10.8B); FY revenue guidance of $44.8B against the $45.7B consensus.
+3.3% · S&P 500 +0.2%
EPS of $1.47 beat the $1.40 estimate on $11.9B revenue (est. $11.8B); FY revenue guidance of $53.2B against the $45.1B consensus.
−4.3% · S&P 500 +0.3%
Where it ended: a close of $51.23 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 3, 2027 (EPS est. $0.77, revenue est. $12.0B).
As of the Nov 10, 2026 close
Replay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GSK and SPY from Benzinga historical bars. Not investment advice.
